With 1.17 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.22 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $4.0 whereas the lowest price it dropped to was $3.0289. The 52-week range on NUWE shows that it touched its highest point at $175.98 and its lowest point at $2.93 during that stretch. It currently has a 1-year price target of $462.00. Beta for the stock currently stands at 0.06.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NUWE was up-trending over the past week, with a rise of 25.41%, but this was up by 18.38% over a month. Three-month performance dropped to -58.24% while six-month performance fell -91.22%. The stock lost -91.85% in the past year, while it has lost -95.65% so far this year.
Float and Shares Shorts:
At present, 0.90 million NUWE shares are outstanding with a float of 0.86 million shares on hand for trading. On 2025-10-15, short shares totaled 40136.0, which was 444.99997 higher than short shares on 1757894400.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, NUWE reported revenue of $1725000.0 and operating income of -$2906000.0. The EBITDA in the recently reported quarter was -$2846000.0 and diluted EPS was -$60.990006.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$944.57264 being high and -$1021.44736 being low. For NUWE, this leads to a yearly average estimate of -$983.01. The surprise factor in the prior quarter was -$18.06.
